MedWatch

GN Hearing eyes opportunities for new product in coming US sales channel

The hearing aid maker forecasts fine chances to sell its new hybrid product, Jabra Enhance Plus, in a soon-to-open sales avenue for cheap hearing aids in the US. "We hold an excellent product from which we think many people could benefit," says CEO Gitte Aabo.

GN Hearing eyes high chances of commercial success in the US' over-the-counter market for cheap hearing aids, guidlines for which are set for release this fall. | Photo: GN Hearing / PR

Denmark's GN Hearing eyes high chances of commercial success in the US channel for cheap over-the-counter (OTC) hearing aids, guidelines for which are expected to be issued this autumn.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs